You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A novel RF coil and incubator for reducing acoustic noise in neonatal MRI

    SBC: NeoView, Inc.            Topic: NICHD

    PROJECT SUMMARY In this Phase I Small Business Technology TransferSTTRprojecta team of researchers at Cincinnati Childrenandapos s Hospital Medical CenterCCHMCwill work with the engineering team at NeoViewIncto design and build novel body coil and incubator prototypes for aTesla Neonatal Intensive Care UnitNICUMRI systemThese components will play a central role in NeoViewandapos s neonatal MRI pro ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Automated Real-Time Trauma Resuscitation Communication System for Clinical Decision Support

    SBC: Lifeboard Medical            Topic: NLM

    PROJECT SUMMARY Despite rapid transport to appropriate facilitiesmany trauma patients needlessly die in the first hour of careTrauma is the leading cause of death for Americans under the age ofand greatest cause of potential life years lost before the age ofexceeding that of either cancer or heart diseaseUp toof traumatic deaths may be preventableIt is estimated that miscommunication is the leadin ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. VGo-Assist, A Mobile Telepresence Robot to Engage Persons with Alzheimer's Disease and Related Dementias

    SBC: VECNA TECHNOLOGIES, INC            Topic: NIA

    PROJECT SUMMARY ABSTRACTThis project s long term purpose is to adapt an existing telepresence robotVecna s VGofor remote care of persons living at home with early stage Alzheimer s and related dementiasADRDIt responds to the NIA s call for development of robots to support care management and independent livingpromote social engagementreduce lonelinessand assist family members and professionals in ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  4. User-driven Retrospectively Supervised Classification Updating (RESCU) systemfor robust upper limb prosthesis control

    SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC            Topic: NINDS

    ABSTRACT Approximately individuals live with upper limb loss loss of at least one hand in the US Fortunately prosthetic devices have advanced considerably in the past decades with the development of dexterous anthropomorphic hands However potentially the most promising used control strategy myoelectric control lacks a correspondingly high level of performance and hence the use of dexterous hands r ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Making Standing Balance The Fifth Vital Sign in Clinical Settings

    SBC: BERTEC CORP            Topic: NIA

    Falls are a significant source of early morbidity and mortality in the aging populationyet the neurologicalsensoryand motor changes that lead to increased fall risk often escape early identification and interventionVital signs are commonly used in clinical settings to assess the cardiovascular systemblood pressureheart rateimmune systembody temperatureand the respiratory systemrespiratory rateto e ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  6. Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.

    SBC: ARCHER PHARMACEUTICALS, INC.            Topic: NIA

    Pathological hallmarks of Alzheimerandapos s diseaseADinclude extracellular deposits of Apeptidesintraneuronal aggregates of abnormally phosphorylated tau protein and neuroinflammationMost proposed AD disease modifying therapies have focused on strategies that reduce brain Aamyloid or tau pathological accumulationHoweversuch approaches have been unsuccessful in late stage AD clinical trials and ma ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. Testing Lifespan/HealthspanPharmacological Interventions inHumanized C. elegans Knock-In Modelsof Dementia

    SBC: NEMAMETRIX, INC            Topic: NIA

    Byovermillion people in the USA will be diagnosed with Alzheimerandapos s related dementia at an annual treatment cost near $billionTo contain the escalation in healthcare costsnew treatments are needed to relieve the underlying genetic causes and risk factors leading to dementia onsetIn simple animal modelsdrugs have been found that lead to lifespan extensionYet the underlying genetic mechanisms ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty

    SBC: Longeveron LLC            Topic: NIA

    Aging Frailty is a biologically driven geriatric syndrome of multisystem physiological decline that is distinct from normal aging and disproportionately increases vulnerability to adverse clinical outcomesFrailty has an overall prevalence ofof thoseyears and olderand there is growing awareness in the geriatric community to diagnose and treat this conditionas it is not an inevitable consequence of ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Development of CDK5-p25 modulator to treat Alzheimer's Disease and Frontotemporal Dementia

    SBC: COGENTIS THERAPEUTICS INC            Topic: NIA

    Post-mortem evidence shows that CDK5, a major kinase for tau and amyloid precursor protein, is hyperactive in the brains of patients with AD. Multiple genome wide association studies link CDK5 alleles to AD. Elegant genetic mouse(5xFAD) and human stem cell-derived neuron studies demonstrate the CDK5 hyperactivity is required (rather than just a correlation) for progression of AD pathology. CDK5 is ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)

    SBC: EVON MEDICS LLC            Topic: NIA

    ABSTRACT The Development and Evaluation of Computerized Olfactory Training ProgramCOTfor Cognitive Decline in Preclinical and Early Alzheimer s DiseaseADis a project to develop a home based brain stimulation device for prevention of AD progression in preclinical and early ADThe success of enriched odor environment for reversal of AD pathology in animals spurred high hopes for translation of olfact ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government